1 – 13 of 13
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
In vivo assessment of anticoagulant and antiplatelet effects of Syzygium cumini leaves extract in rabbits
(
- Contribution to journal › Article
- 2003
-
Mark
Treatment of the bleeding inhibitor patient
(
- Contribution to journal › Article
- 2002
-
Mark
Factor Va-factor Xa interactions: molecular sites involved in enzyme:cofactor assembly.
(
- Contribution to journal › Article
- 2001
-
Mark
A functional prothrombin gene product is synthesized by human kidney cells
(
- Contribution to journal › Article
-
Mark
Synthesis of gamma-carboxylated polypeptides by alpha-cells of the pancreatic islets
(
- Contribution to journal › Article
- 2000
-
Mark
Interaction of Triglyceride-rich Lipoproteins with Platelets and Vitamin K-dependent Coagulation Factors
2000)(
- Thesis › Doctoral thesis (compilation)
- 1999
-
Mark
Sources of Arachidonic Acid in Platelets, Bone, Marrow and Gastrointestinal Tract
1999)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Thrombophilia as a multigenic disease
(
- Contribution to journal › Article
- 1998
-
Mark
Structure and distribution of alpha-1-microglobulin proteins
1998)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
(
- Contribution to journal › Letter
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
(
- Contribution to journal › Letter
- 1997
-
Mark
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
(
- Contribution to journal › Debate/Note/Editorial
- 1996
-
Mark
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
(
- Contribution to journal › Article